Gyre Therapeutics (GYRE) Change in Inventory (2023 - 2026)

Gyre Therapeutics (GYRE) has 4 years of Change in Inventory data on file, last reported at $1.0 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at $1.0 million, down 34.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 3.02% YoY), and the FY2025 annual result was $3.6 million, up 69.75% from the prior year.
• Change in Inventory fell to $1.0 million in Q1 2026 per GYRE's latest filing, from $1.2 million in the prior quarter.
• Over five years, Change in Inventory peaked at $1.5 million in Q1 2025 and troughed at -$921000.0 in Q3 2023.
• A 4-year average of $387538.5 and a median of $636000.0 in 2024 frame the typical range for Change in Inventory.
• On a YoY basis, Change in Inventory climbed as much as 923.73% in 2025 and fell as far as 111.32% in 2025.
• A 4-year view of Change in Inventory shows it stood at -$184000.0 in 2023, then jumped by 164.13% to $118000.0 in 2024, then soared by 923.73% to $1.2 million in 2025, then slipped by 15.98% to $1.0 million in 2026.
• Business Quant data shows GYRE's Change in Inventory at $1.0 million in Q1 2026, $1.2 million in Q4 2025, and -$72000.0 in Q3 2025.